Ticker archive · $IOVA

$IOVA Filing Signals & Market Reactions

Delayed, SEO-crawlable recaps of AI-scored catalysts for $IOVA — including observed post-filing price moves. Live streaming stays exclusive to VIP.

? All delayed signals

$IOVA

$IOVA – Iovance Reports Updated IOV-LUN-202 Data, Plans Lifileucel sBLA in 2027

IOVANCE BIOTHERAPEUTICS, INC.

2026-10-29 00:00:00 UTC · SEC_8K · All $IOVA

?? Positive AI Sentiment (+3.0 / 10)

Overall response rate (ORR) reached 24.6% (17/69 patients) in non-squamous mNSCLC.
KRAS wild-type subgroup demonstrated a 43.3% ORR (13/30), driving biomarker enrichment strategy.
Planned supplemental Biologics License Application (sBLA) for lifileucel scheduled for 2027.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing ?